Grapefruit USA Executes Binding Letter Of Intent To Acquire Diagnostic Lab Corporation
Grapefruit USA Executes Binding Letter Of Intent To Acquire Diagnostic Lab Corporation
Grapefruit USA, Inc. (OTCQB:GPFT) executed a binding letter of intent, entered into on June 30, 2022, by the company and Diagnostic Lab Corporation of Englewood Cliffs, New Jersey, pursuant to which the company and DLC will jointly recapitalize Grapefruit and raise $12.5 million of debt financing (including $5.5 million already committed from a qualified construction lender) to:
葡萄柚美國公司(OTCQB：GPFT)執行邊具有約束力的意向書，於2022年6月30日生效，由.c公司和診斷實驗室公司新澤西州恩格爾伍德懸崖，據此，該公司和DLC將聯合對葡萄柚進行資本重組，籌集1250萬美元債務融資(包括一家合格建築貸款人已經承諾的550萬美元)用於：
1. Complete construction of the company's "Mothership" cultivation, manufacturing and distribution facility in the Coachillin' Industrial Cultivation and Ancillary Canna-Business Park, located 14 miles north of downtown Palm Springs, California.
1. 完整的建造c公司的“母公司”種植、製造和分銷設施設在Coachlin的工廠化種植和輔助美人魚-商務園，位於加州棕櫚泉市中心以北14英里處。
2. Acquire all of DLC's assets for a to-be-determined amount of cash and Grapefruit common shares.
2. 收購DLC的所有資產現金和葡萄柚普通股的金額待定。
3. Fund the company's application for an FDA 510K approval for its patented Hourglass time release Z-POD THC/CBD/cannabinoid infused delivery cream.
3. 為該基金c公司申請FDA 510K批准其專利沙漏時間釋放Z-POD THC/CBD/大麻素輸液分娩乳膏。
4. Fund the company's clinical study to measure the effects of the Hourglass delivery cream on the pain and other symptoms of patients who suffer from the debilitating effects of osteoarthritis.
4. 為該基金c歐姆帕尼的臨牀研究測量沙漏遞送霜對患有骨關節炎衰弱效應的患者疼痛和其他症狀的影響。
The parties plan to retire the $12.5 million of new debt through a public equity capital raise and concurrent up-list to a U.S. or Canadian exchange, as applicable securities regulations permit.
雙方計劃通過公開股權融資償還1,250萬美元的新債務，並在適用證券法規允許的情況下同時在美國或加拿大的交易所上市。
Bradley J. Yourist, Grapefruit's CEO and co-founder, stated, "Execution of this letter of intent between DLC and GPFT is the next step in Grapefruit's evolution from a 'me too' cannabis company to a medical science-based, canna-focused biotech company that will develop and obtain regulatory approval for an ever-expanding line of proprietary cannabis products based on the company's patented Hourglass technology."
布拉德利·J·尤里斯特葡萄柚公司首席執行官兼聯合創始人表示：“DLC和GPFT簽署的這份意向書是葡萄柚公司從一家‘Me Too’大麻公司演變為一家以醫學科學為基礎、以美人掌為重點的生物技術公司的下一步，該公司將開發基於公司專利沙漏技術的不斷擴大的專有大麻產品線，並獲得監管部門的批准。”
Yourist continued: " Construction of the Coachillin' 'Mothership' facility at the Coachillin' Park will secure our balance sheet and provide a reliable source of reasonably priced pharma-quality cannabis flowers for raw material for THC Hourglass products and for distribution in both the U.S. and Canada, as appropriate under any given market circumstances. The 510K approval for the Hourglass technology will facilitate its rapid market acceptance throughout the United States as an approved medical device. Finally, our lab acquisition program will provide rapid revenue growth and expand the company's cannabis industry footprint. "
Yourist繼續説道：“Coachlin‘Park’‘Mothership’設施的建設將確保我們的資產負債表安全，並提供價格合理的藥用優質大麻花的可靠來源，作為沙漏產品的原材料，並在任何給定的市場環境下適當地在美國和加拿大分銷。沙漏技術的510K批准將促進其作為經批准的醫療設備在整個美國迅速被市場接受。最後，我們的實驗室收購計劃將提供快速的收入增長，並擴大公司的大麻行業足跡。“
The parties expect to finalize and execute the definitive agreement before the end of August 2022 and close the transaction shortly thereafter.
雙方預計在2022年8月底之前敲定並執行最終協議，並在不久之後完成交易。
Photo by CRYSTALWEED cannabis on Unsplash
結晶器大麻在Unspash上的照片
Related News
相關新聞s
Health Canada Approves Grapefruit USA's Hourglass Time Release THC+CBD Delivery Cream For Sale
加拿大衞生部批准美國沙漏時間釋放THC+CBD遞送霜銷售
California Distribution Secured For Grapefruit's Cannabis Concentrate Brand 'Summit Boys'
加州獲得葡萄柚大麻濃縮品品牌“Summit Boys”的分銷
Canna-Biotech Co. Grapefruit USA Signs Term Sheet With Dubai-Based Lender To Build GPFT 'Mothership'
Canna-Biotech Co.美國葡萄柚公司與總部位於迪拜的貸款機構簽署條款説明書，建立GPFT“母公司”
譯文內容由第三人軟體翻譯。